On 29th January 2021, the World Health Organization (WHO) released the third edition of its Model List of Essential In Vitro Diagnostics (EDL). This edition includes WHO-recommended Covid-19 tests (nucleic acid as well as antigen detection tests), expands the suite of tests for vaccine-preventable and infectious diseases and non-communicable diseases (such as cancer and diabetes), and introduces a section on endocrinology. Country governments must now adopt and adapt the WHO EDL, to ensure improved access to diagnostics in countries.
Read more at Forbes: To Improve Access To Diagnostics, Countries Must Adapt The WHO Essential Diagnostics List